{"public_id":"co_3cf6ebc69cb3c32a9bb40d25c60c9332","status":"active","merged_into_public_id":null,"resolved_public_id":"co_3cf6ebc69cb3c32a9bb40d25c60c9332","name":"tenofovir","description":"An antiviral nucleotide analogue used to treat chronic hepatitis B infection.","aliases":[],"types":["antiviral drug","nucleos(t)ide analogue"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":207602966,"title":"Recent advances in prevention of hepatitis B recurrence after liver transplantation.","citation_count":13,"url":"https://sah.borca.ai/papers/207602966"}],"claims":[{"public_id":"cl_8f851a7afbbd50e55d4a07e76b8a1f12","text":"Multiple prophylactic regimens using entecavir, tenofovir, or lamivudine plus adefovir, with or without HBIG, are now adopted in several liver transplant centers.","corpus_id":207602966,"url":"https://sah.borca.ai/claims/cl_8f851a7afbbd50e55d4a07e76b8a1f12"},{"public_id":"cl_9e20d34c050fe0f18e46df4846ae4d36","text":"Entecavir and tenofovir have replaced lamivudine as the first choice for preventing hepatitis B recurrence after liver transplantation.","corpus_id":207602966,"url":"https://sah.borca.ai/claims/cl_9e20d34c050fe0f18e46df4846ae4d36"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_3cf6ebc69cb3c32a9bb40d25c60c9332","url":"https://sah.borca.ai/concepts/co_3cf6ebc69cb3c32a9bb40d25c60c9332"}